Jeffrey M Drazen. Show Affiliations »
Abstract
Entities: Chemical
Mesh： See more » Cyclooxygenase 2 Inhibitors/adverse effectsEthics, ResearchHumansLactones/adverse effectsPeriodicals as Topic/ethicsRandomized Controlled Trials as TopicSulfones/adverse effectsUnited States
Substances： See more » Cyclooxygenase 2 InhibitorsLactonesSulfonesrofecoxib
Year: 2006 PMID： 17021294 PMCID： PMC1592060 DOI： 10.1177/014107680609901003
Source DB: PubMed Journal: J R Soc Med ISSN： 0141-0768 Impact factor: 18.000